Anzeige
Mehr »
Mittwoch, 22.04.2026 - Börsentäglich über 12.000 News
Diese Aktie zündet die nächste Explorationsstufe - und der Markt beginnt aufzuwachen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
218 Leser
Artikel bewerten:
(1)

Digital Twins in Healthcare Market worth $101.19 billion by 2031 | MarketsandMarkets

DELRAY BEACH, Fla., April 22, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Digital Twins in Healthcare Market is projected to grow from about USD 7.47 billion in 2026 to USD 101.19 billion by 2031, at a CAGR of 68.4%.

Browse through 110 market data tables and 40 figures spread across 180 pages and the in-depth TOC on the "Digital Twins in Healthcare Market - Global Forecast to 2031"

Digital Twins in Healthcare Market Size & Forecast:

  • Market Size Available for Years: 2025-2031
  • 2026 Market Size: USD 7.47 billion
  • 2031 Projected Market Size: USD 101.19 billion
  • CAGR (2026-2031): 68.4%

Digital Twins in Healthcare Market Trends & Insights:

  • By type, the body part twins segment is projected to register the fastest growth of 69.0% in the global digital twins in healthcare market.
  • In 2025, by component, the software segment accounted for the largest share of 58.1% of the digital twins in healthcare market.
  • By region, North America accounted for the largest share of 48.2% of the global digital twins in healthcare market in 2025.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74014375

The market is growing at a remarkable pace, mainly due to increased investments, technological innovations, and rising acceptance in clinical research and healthcare provision. Digital twins represent simulated models of patients, organs, and other aspects of the healthcare system as technologies advance into predictive and data-driven healthcare delivery. Thousands of clinical studies currently registered on ClinicalTrials.gov show that there is an emerging interest in developing advanced techniques involving the use of virtual simulations and modeling for efficient trial processes. Moreover, the rise in investment activities further promotes innovation within the industry. For instance, Twin Health (US), which utilizes digital twin technology to create personalized metabolic health products, made headlines when it raised another USD 50 million after its earlier USD 140 million Series C fundraising. The firm seeks to develop and scale up its digital twin platform, which combines AI technology and simulation in providing healthcare services. Moreover, regulatory agencies, including the FDA in the United States, are encouraging computational modeling and simulations in order to increase or decrease the number of traditional clinical trials conducted. With healthcare organizations relying more and more on real-time data collected through wearables, imaging technology and electronic health records, digital twins are contributing towards better predictions of illness progression and therapeutic effects.

By type, the body part twins segment is expected to register the fastest growth in the digital twins in healthcare market during the forecast period.

the market for digital twins in healthcare has been divided into process twins, system twins, whole body twins, and body part twins, with the body part twins segment expected to witness the highest growth rate in the forecast period. Such a tendency can be explained by an increasing number of cases when digital models for certain organs are applied in clinical practice. Unlike whole-body digital models, organ models are much simpler and thus easier to implement in medical practice and to validate. They can be used for personalized medicine applications to help plan treatment, simulate surgery and assess how diseases progress. Moreover, recent developments prove that such a trend is likely to become even stronger. Namely, there has been an example when digital twin models of certain organs, such as the esophagus and heart, have been used in hospitals to simulate the results of surgical intervention. In addition, a wider application of AI, IoT, and real-time data in medicine means that the development of organ models becomes faster and more efficient than the development of whole-body models.

Request Sample Pages@https://www.marketsandmarkets.com/requestsampleNew.asp?id=74014375

By end user, the healthcare providers segment accounted for the largest share of the digital twins in healthcare market.

the digital twins in healthcare market is segmented into pharma & biopharma companies, research & academia, healthcare providers, medical device companies, and other end users (payers, diagnostic labs, patients, and CROs). Healthcare providers accounted for the largest share of the digital twins in healthcare market in 2025. This high growth is attributed to the improved diagnostic ability in hospitals, increased adoption of telemedicine & telehealth in the healthcare industry and increasing digital twin adoption in the healthcare industry. Also, digital twins will help to plan and design hospitals by modeling different floor plans, layout plans, and workflows.

North America registered the largest share in the global digital twins in healthcare market in 2025.

The region's leadership in this area is mainly characterized by the prevalence of the adoption of advanced digital technologies, well-developed infrastructure for healthcare information technology, and active involvement in clinical research. The leading country here is the US due to increased adoption of AI technologies, real-world data, and simulation in both clinical practice and research. Besides, the contribution to the spread of digital twins has been made by the US Food and Drug Administration, which promotes the use of modeling and simulation technologies in drug development. Another reason why the US occupies the leading position in terms of adoption of digital twin technologies is that there are many reputable healthcare organizations and clinics, such as Mayo Clinic and Massachusetts General Hospital, conducting clinical studies focused on the application of AI and data analysis for personalized medicine. Finally, digital twin solutions have become more advanced thanks to technology developers such as Microsoft Corporation and GE HealthCare, who develop digital twin technology based on cloud technology and advanced imaging systems.

Inquire Before Buying@https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=74014375

Top Companies in Digital Twins in Healthcare Market:

The Top Companies in Digital Twins in Healthcare Market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systèmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Related Reports:

Drug Discovery Services Market - Global Forecast to 2030

Healthcare IT Market - Global Forecast to 2030

Healthcare Education Market - Global Forecast to 2028

Healthcare Analytics Market - Global Forecast to 2030

IoT Medical Devices Market - Global Forecast to 2030

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/digital-twins-in-healthcare-market-worth-101-19-billion-by-2031--marketsandmarkets-302750019.html

© 2026 PR Newswire
Energiepreisschock - Diese 3 Werte könnten langfristig abräumen!
Die Eskalation im Iran-Konflikt hat die Energiepreise mit voller Wucht nach oben getrieben. Was zunächst nach einer kurzfristigen Reaktion aussah, entwickelt sich zunehmend zu einem strukturellen Problem: Die Straße von Hormus ist blockiert, wichtige LNG- und Ölanlagen stehen still oder werden gezielt angegriffen. Eine schnelle Entspannung ist nicht in Sicht – im Gegenteil, die Lage spitzt sich weiter zu.

Für die Weltwirtschaft bedeutet dies wachsende Risiken. Steigende Energiepreise erhöhen den Inflationsdruck, gefährden Zinssenkungen und bringen die ohnehin hoch bewerteten Aktienmärkte ins Wanken. Doch wo Risiken entstehen, ergeben sich auch Chancen.

Denn von einem dauerhaft höheren Energiepreisniveau profitieren nicht nur Öl- und Gasunternehmen. Auch Versorger, erneuerbare Energien sowie ausgewählte Rohstoff- und Agrarwerte rücken in den Fokus. In diesem Umfeld könnten gezielt ausgewählte Unternehmen überdurchschnittlich profitieren – unabhängig davon, ob die Krise anhält oder nicht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die genau dieses Profil erfüllen: Krisenprofiteure mit solidem Geschäftsmodell, attraktiver Bewertung und langfristigem Potenzial.

Jetzt den kostenlosen Report sichern – und Ihr Depot auf den Energiepreisschock vorbereiten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.